A more personalized treatment for people with a type of metastatic liver cancer –hepatocellular carcinoma — may be possible by targeting the protein c-Met, according to Penn State College of Medicine researchers. Hepatocellular carcinoma (HCC) is …
Two new studies have determined that everolimus-eluting stent (EES) implantation reduced the incidence of restenosis and repeat revascularization in patients with calcified culprit lesions, and had fewer clinical events. Results show the rate of maj…
(SACRAMENTO, Calif.) — A study of the options for reducing cancer incidence and mortality among women who have been treated for precancerous cervical lesions found that an annual conventional Pap smear is a cost effective strategy.
Joy Melniko…
BOSTON — — Raising the survival rate of children with sarcoma in low-income countries will require steps to diagnose the disease sooner, train cancer pathologists, expand radiation therapy services, create multi-specialty teams to review each cas…
Researchers at Yale School of Medicine have found that new disease pathways involving more than one cell type leads to Type 1 Gaucher disease, a rare genetic disorder in which fatty substances called glycosphingolipids accumulate in cells, res…
WASHINGTON, Oct. 18 — Can skin cancer be treated with light? Scientists at the University of California, Irvine (UC Irvine), believe so. They’re exploring new ways to image cancerous lesions using LEDs that might advance a technique for treating c…
A first-ever, long-term study of patients who underwent robot-assisted surgery to remove their cancerous prostates found that nearly 87 percent of them had no recurrence of the disease after five years.
The findings were reported in this month’s i…
(Phoenix, Arizona October 15, 2010) — An internationally-recognized gynecologic oncologist at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona is warning that the results from a long-awaited global study of ovarian cancer should be view…
TORONTO, Ont., October 13, 2010 — A new material similar to that used by the U.S. Military to treat traumatic injuries is showing promise as the next novel treatment for bleeding ulcers, a condition that commonly affects up to 15 per cent of a…
Adding topotecan to carboplatin plus paclitaxel, the standard treatment for ovarian cancer, does not improve progression-free survival in patients and leads to greater toxicity, according to a study published online October 11 in the Journal of the …
INDIANAPOLIS — Twenty-two physical symptoms associated with cancer — symptoms often unrecognized and undertreated — are prevalent in all types of cancers regardless of whether the patient is newly diagnosed, undergoing treatment or is a …
For patients with advanced lung cancer whose tumors carry EGFR activating mutations, first-line treatment with erlotinib nearly tripled progression-free survival compared to a standard chemotherapy combination, show results from the first prospect…